EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Tumor–Platelet–Immune Interface: Driving Metastasis, Pre-Metastatic Niche Formation and Therapeutic Vulnerabilities

Jalal Naghinezhad, Ehsan Kamali Yazdi, Ahmad Mohajerian, Negin Yousefi Chermehini, Pedram Ghanavati, Hamid Motamedi, Hadi Rezaeeyan

Expert Reviews in Molecular Medicine · 2026 · 28

DOI: 10.1017/erm.2026.10043 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Expert Reviews in Molecular Medicine, online erschienen am 07.04.2026. Verfasst von Jalal Naghinezhad und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Sciences, School of Allied Medical Science, https://ror.org/01rs0ht88Mazandaran University of Medical Sciences, Sari…. Hauptthemen laut MEDLINE: Blood Platelets, Tumor Microenvironment, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metastatic dissemination remains the leading cause of cancer-related mortality, driven not only by tumor-intrinsic factors but also by dynamic interactions within the tumor microenvironment (TME). Platelets and leukocytes orchestrate a systemic pro-metastatic network by shielding circulating tumor cells (CTCs), inducing neutrophil extracellular trap (NET) formation, and remodeling the extracellular matrix to prime pre-metastatic niches. This platelet-leukocyte crosstalk simultaneously promotes immune evasion, thromboinflammation, and metastatic seeding, creating a multi-cellular, temporally coordinated program that conventional anti-platelet and anti-inflammatory therapies inadequately target. Here, we propose a next-generation, multi-stimuli-responsive nanoparticle platform designed to disrupt these interconnected metastatic circuits. Engineered to respond to acidic pH in primary tumors and matrix metalloproteinases in pre-metastatic niches, these nanoparticles enable spatiotemporally controlled release of cytotoxic agents, anti-platelet drugs, and immune checkpoint inhibitors. Surface functionalization with anti-P-selectin further enhances specificity to tumor vasculature and facilitates platelet ‘hitchhiking’ for targeting CTCs. By simultaneously neutralizing platelet-leukocyte interactions, inhibiting NET-mediated scaffolds, and restoring anti-tumor immunity, this integrated strategy addresses multiple pro-metastatic mechanisms in a coordinated fashion. This work provides a conceptual and translational framework for precision anti-metastatic therapeutics, transforming the paradigm from single-pathway interventions to network-targeted strategies that disrupt tumor progression, CTC survival and metastatic niche formation. Our approach represents a critical step toward actionable, multi-modal interventions capable of preventing metastatic disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood PlateletsTumor MicroenvironmentNeoplasmsHumansAnimalsNeoplasm MetastasisNeoplastic Cells, CirculatingNanoparticlesLeukocytes

Stichwörter der Autor:innen

circulating tumor cellsenzyme- and pH-sensitive nanoparticlehydrogelneutrophil extracellular trapsplatelet-leukocyte crosstalkpre-metastatic nichetumor microenvironment

Autor:innen und Institutionen

  • Department of Medical Laboratory Sciences, School of Allied Medical Science, https://ror.org/01rs0ht88Mazandaran University of Medical Sciences, Sari, Iran.
  • https://ror.org/03hh69c20Alborz University of Medical Sciences, Alborz, Iran.
  • Department of Emergency Medicine, Faculty of Medicine, https://ror.org/01rws6r75Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • https://ror.org/01c4pz451Department of Neurosurgery, Firouzgar Hospital, Iran University of Medical Sciences (IUMS), Tehran, Iran.
  • https://ror.org/01d30w739Asadabad School of Medical Sciences, Asadabad, Iran.

Zitieren

APA

Naghinezhad, J., Kamali Yazdi, E., Mohajerian, A., Yousefi Chermehini, N., Ghanavati, P., Motamedi, H., & Rezaeeyan, H. (2026). The Tumor–Platelet–Immune Interface: Driving Metastasis, Pre-Metastatic Niche Formation and Therapeutic Vulnerabilities. Expert Reviews in Molecular Medicine, 28. https://doi.org/10.1017/erm.2026.10043

Vancouver

Naghinezhad J, Kamali Yazdi E, Mohajerian A, Yousefi Chermehini N, Ghanavati P, Motamedi H, et al. The Tumor–Platelet–Immune Interface: Driving Metastasis, Pre-Metastatic Niche Formation and Therapeutic Vulnerabilities. Expert Reviews in Molecular Medicine. 2026;28. doi:10.1017/erm.2026.10043

BibTeX
@article{Naghinezhad2026,
  author = {Naghinezhad, Jalal and Kamali Yazdi, Ehsan and Mohajerian, Ahmad and Yousefi Chermehini, Negin and Ghanavati, Pedram and Motamedi, Hamid and Rezaeeyan, Hadi},
  title = {The Tumor–Platelet–Immune Interface: Driving Metastasis, Pre-Metastatic Niche Formation and Therapeutic Vulnerabilities},
  journal = {Expert Reviews in Molecular Medicine},
  year = {2026},
  volume = {28},
  doi = {10.1017/erm.2026.10043}
}
Kostenlos starten →